Condition: Opioid Abuse and Addiction · Sponsor: ReacX Pharmaceuticals, Inc.
The goal of this clinical trial is to learn how safe either one or two nalmefene implants are after remaining implanted for 4 or 12 weeks. Additionally the pharmacokinetics (PK), how fast the drug is absorbed into the body and how long it remains in the body, will also be studies. The data collected in this healthy volunteer study will inform the Sponsor on how best to proceed with future trials in the intended patient population.
This description comes directly from the study's public registry record.
Rajesh Patel, PhD · 1-833-824-0824 · rpatel@reacxpharma.com
Susan Lee · slee@reacxpharma.com
Always discuss trial participation with your own doctor first.
| Premier Research | Morrisville, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07325279